跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45,608 条关于
“steroid-refractory acute GvHD”
全部
45,608
临床试验
39,955
药物
409
机构
34
资讯
5,210
11个月前
Xenopax Demonstrates Superior Efficacy in Steroid-Refractory Acute GVHD Treatment
2年前
FDA Accepts Resubmitted BLA for Remestemcel-L in Pediatric Steroid-Refractory Acute GVHD
2个月前
GvHD Pipeline 2026: Cell-Based, Microbiome and Targeted Therapies Reshape Treatment Landscape
去年
ReAlta Life Sciences Receives European Orphan Drug Designation for Graft-versus-Host Disease Treatment
24年前
Early Antithymocyte Globulin Therapy Enhances Survival in Steroid-Resistant Acute GVHD Patients
去年
REACH3 Trial Update: Ruxolitinib Shows Promising Efficacy in Steroid-Refractory Chronic GVHD
去年
Ruxolitinib Shows Superior Efficacy in Steroid-Refractory Chronic GVHD with 38-Month Median Failure-Free Survival
9个月前
ReAlta Reports Promising Phase 2 Results for Pegtarazimod in Steroid-Refractory Acute Graft-Versus-Host Disease
去年
ECP Treatment Shows Promising Results for Steroid-Resistant Chronic GVHD Patients
去年
Chronic GVHD Treatment Evolution: Biomarker-Guided Therapy and Steroid-Free Approaches Show Promise
第 1 页，共 521 页
上一页
下一页
